-
Pooled data suggest sotatercept as novel disease-modifying therapy for PAH
Aaron B. Waxman, MD, PhD, FCCP, said he believes the drug will become a first-line therapy option, but questions remain regarding when to initiate treatment.
Recent News
-
Capillary refill time: Advancing perfusion-targeted resuscitation in septic shock
Capillary refill time is a quick, noninvasive tool to assess perfusion and microvascular health in shock. It offers faster feedback than lactate levels and may improve resuscitation outcomes.
-
Delving deeper into the molecular genetics of idiopathic pulmonary fibrosis
William Whalen II, MD, MS, reflects on his experience as a recipient of the 2023 CHEST Research Grant in Pulmonary Fibrosis and how it has affected his professional trajectory.
-
Top reads from the CHEST journal portfolio – May 2025
Editorial Board members share their insights on journal articles about CT scan analysis in RA-ILD, asthma and COPD exacerbations in adults in the ICU, and racialized economic disparities in NSCLC care and outcomes.
-
COPD: Could there be a GLP-1 for that?
While real-world data are promising, experts Dinah Foer, MD, and William B. Feldman, MD, say more randomized controlled trials are needed to confirm whether antihyperglycemic medications can improve respiratory outcomes in patients with comorbid type 2 diabetes and COPD.
-
Study highlights importance of lactation among many new mothers in ICU
Researcher, Kayla Kolbe, MD, said even in the face of critical illness, patients feel strongly about lactation.
-
TETON trials could herald multimodal approach to IPF
Steven Nathan, MD, said the addition of inhaled treprostinil would offer a novel approach that would allow clinicians to target the disease on two fronts.